首页> 外文期刊>Colloids and Surfaces, B. Biointerfaces >Inherently antioxidant and antimicrobial tannic acid release from poly(tannic acid) nanoparticles with controllable degradability
【24h】

Inherently antioxidant and antimicrobial tannic acid release from poly(tannic acid) nanoparticles with controllable degradability

机译:从可降解性可控的聚(单宁酸)纳米颗粒中释放出固有的抗氧化剂和抗菌单宁酸

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

From a natural polyphenol, Tannic acid (TA), poly(TA) nanoparticles were readily prepared using a single step approach with three different biocompatible crosslinkers; trimethylolpropane triglycidyl ether (TMPGDE), poly(ethylene glycol) diglycidyl ether (PEGGE), and trisodium trimetaphosphate (STMP). P(TA) particles were obtained with controllable diameters between 400 to 800 nm with -25 mV surface charge. The effect of synthesis conditions, such as the emulsion medium, pH values of TA solution, and the type of crosslinker, on the shape, size, dispersity, yield, and degradability of poly(Tannic Acid) (p(TA)) nanoparticles was systematically investigated. The hydrolytic degradation amount in physiological pH conditions of 5.4, 7.4, and 9.0 at 37.5 degrees C were found to be in the order TMPGDE < PEGGE < STMP. Furthermore, the degradation amounts of TA from p(TA) nanoparticles can be controlled by the appropriate choice of crosslinker, and the pH of releasing media. The highest TA release, 600 mg/g, was obtained for TMPGDE-crosslinked p(TA) particles in intestinal pH conditions (pH 9) over 3 days; whereas, a slow and linear TA release profile over almost 30 days was obtained by using PEGGE-crosslinked p(TA) in body fluid pH conditions (pH 7.4). The total phenol content of p(TA) particles was calculated as 70 +/- 1 mu g mL(-1) for 170 mu g mL(-1) p(TA), and the trolox equivalent antioxidant capacity was found to be 2027 +/- 104 mM trolox equivalent g(-1). Moreover, p(TA) nanoparticles demonstrated strong antimicrobial effects against common bacterial strains. More interestingly, with a higher concentration of p(TA) particles, higher blood clotting indices were obtained. (C) 2016 Elsevier B.V. All rights reserved.
机译:从天然多酚鞣酸(TA)中,可以很容易地使用一步法制备具有三种不同生物相容性交联剂的聚(TA)纳米颗粒。三羟甲基丙烷三缩水甘油醚(TMPGDE),聚(乙二醇)二缩水甘油醚(PEGGE)和三偏磷酸三钠(STMP)。获得P(TA)粒子,其可控制直径在400至800 nm之间,表面电荷为-25 mV。合成条件(如乳液介质,TA溶液的pH值和交联剂的类型)对聚鞣酸(p(TA))纳米颗粒的形状,尺寸,分散性,产率和可降解性的影响为系统地调查。发现在37.5℃在5.4、7.4和9.0的生理pH条件下的水解降解量为TMPGDE <PEGGE <STMP。此外,可以通过适当选择交联剂和释放介质的pH值来控制p(TA)纳米颗粒中TA的降解量。在肠道pH条件(pH 9)下,经过3天,TMPGDE交联的p(TA)颗粒的最高TA释放量为600 mg / g。而在体液pH条件(pH 7.4)下,使用PEGGE交联的p(TA),可以得到近30天缓慢而线性的TA释放曲线。对于170μg mL(-1)p(TA),计算出p(TA)颗粒的总苯酚含量为70 +/- 1μgmL(-1),发现trolox当量抗氧化剂容量为2027 +/- 104 mM trolox当量g(-1)。此外,p(TA)纳米粒子表现出对常见细菌菌株的强大抗菌作用。更有趣的是,随着更高浓度的p(TA)颗粒,获得了更高的凝血指数。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号